このエントリーをはてなブックマークに追加


ID 32303
JaLCDOI
フルテキストURL
fulltext.pdf 1.25 MB
著者
Ogawa, Norio Okayama University
抄録

Levodopa is the gold standard for the treatment of Parkinson's disease (PD) because of its outstanding clinical efficacy. However, the majority of patients experience various adverse reactions, including the wearing-off phenomenon, the on-off phenomenon, dyskinesia and psychiatric symptoms. The response to levodopa depends not only on the intrinsic responsiveness of the patients, but also on various other important factors including the type of levodopa preparation, its absorption/metabolism, the blood-brain barrier, age at onset of disease and concomitant use of anti-parkinsonian drugs. This review summarizes factors which influence the effects of levodopa in PD. To minimize levodopa-induced adverse reactions and to relieve long-term parkinsonian symptoms, levodopa therapy should be conducted by taking these factors into consideration.

キーワード
dopamine agonist
monoamine oxidase-B(MAO-B) inhibitor
catechol-O-methyltransferase(COMT)inhibitor
blood-brain barrier
age at onset
large neutral amino acids
gastric acidity
Amo Type
Review
出版物タイトル
Acta Medica Okayama
発行日
2000-06
54巻
3号
出版者
Okayama University Medical School
開始ページ
95
終了ページ
101
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
英語
論文のバージョン
publisher
査読
有り
PubMed ID
Web of Science KeyUT